Cone Beam Computed Tomography image guided radiation therapy for prostate cancer to improve treatment accuracy and outcomes.
Phase 1
Completed
- Conditions
- Prostate CancerCancer - Prostate
- Registration Number
- ACTRN12609000512224
- Lead Sponsor
- Perth Radiation Oncology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Male
- Target Recruitment
- 75
Inclusion Criteria
Histologically confirmed prostate adenocarcinoma Localised prostate cancer of any T-stage Gleason score and Prostate Specific Antigen (PSA)
Planned by Computed Tomography (CT) study for radical radiotherapy that is - 7400 centigrays (cGy) in 37 fractions. Informed consents obtained for treatment and for clinical study
Exclusion Criteria
Prior radical prostatectomy.
Prior high dose pelvic radiation therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method